SIDA E INFECCIONES VIH
University Medical Center Utrecht
Utrecht, HolandaPublications en collaboration avec des chercheurs de University Medical Center Utrecht (8)
2022
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340
2016
-
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
Clinical Infectious Diseases, Vol. 62, Núm. 5, pp. 655-663
2015
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
-
Primary resistance to integrase strand-transfer inhibitors in Europe
Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 10, pp. 2885-2888
2014
-
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
BMC Infectious Diseases, Vol. 14, Núm. 1
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2013
-
Limited cross-border infections in patients newly diagnosed with HIV in Europe
Retrovirology, Vol. 10, Núm. 1